Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 6, 2006, Pages 734-738

  De Schryver, E L L M ^a,b   Algra, A ^a   Donders, R C J M ^c   Van Gijn, J ^b   Kappelle, L J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ARTICLE; BLINDNESS; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ECHOGRAPHY; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RETINA BLOOD VESSEL OCCLUSION; RETINA ISCHEMIA; STROKE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HEMISPHERIC DOMINANCE; INFARCTION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; RETINA BLOOD VESSEL; RISK FACTOR; TRANSITIONAL BLINDNESS;

AGED; AMAUROSIS FUGAX; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; INFARCTION; MALE; MIDDLE AGED; RETINA; RETINAL VESSELS; RISK FACTORS;

EID: 33646846070     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.085613     Document Type: Article

References (25)

1. Fisher M. Transient monocular blindness associated with hemiplegia. Am Aren Opthalmol 1952;47:167-203.
2. Poole O, Ross Russell RW. Mortality and stroke after amaurosis fugax. J Neurol Neurosurg Psychiatry 1985;48:902-5.
3. Hurwitz BJ, Heyman A, Wilkinson WE, et al. Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study. Ann Neurol 1985;18:698-704.
4. Wilterdink JL, Easton JD. Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol 1992;49:857-63.
5. Streifler JY, Eliasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995;52:246-9.
6. Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001;345:1084-90.
7. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1991;54:793-802.
8. Donders RC, Kappelle U, Algra A, et al. Subtypes of transient monocular blindness and subsequent risk of vascular complications. Cerefarovasc Dis 1996;6:241-7.
9. Hankey GJ, Slattery JM, Warlow CP. Prognosis and prognostic factors of retinal infarction: a prospective cohort study. BMJ 1991;302:499-504.
10. Mead GE, Lewis SC, Wardlaw JM, et al. Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes. Stroke 2002;33:2383-90.
11. Anderson DC, Kappelle LJ, Eliasziw M, et al. Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke 2002;33:1963-7.
12. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24.
13. Kappelle LJ, van Latum JC, van Swieten JC, et al. Recurrent stroke after transient ischaemic attack or minor ischaemic stroke: does the distinction between small and large vessel disease remain true to type? Dutch TIA Trial Study Group. J Neurol Neurosurg Psychiatry 1995;59:127-31.
14. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991;325:1261-6.
15. Danders RC. Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery. J Neurol Neurosurg Psychiatry 2001;71:247-9.
16. De Schryver ELLM, on behalf of the European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Group. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. Cerebrovasc Dis 2000;10:147-50.
17. De Schryver ELLM, on behalf of the European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Group. ESPRIT: protocol change. Cerebrorasc Dis 2001;11:286.
18. van Wijk I, Kappelle LJ, van Gijn J, et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005;365:2098-104.
19. Bamford JM, Sandercock PAG, Warlow CP, et al. Interobserver agreement for the assessment of handicap in stroke patients [letter]. Stroke 1989;20:828.
20. Kappelle LJ, van Latum JC, Koudstaal PJ, et al Transient ischaemic attacks and small-vessel disease. Dutch TIA Study Group. Lancet 1991;337:339-41.
21. Anon. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. The Dutch TIA Trial Study Group. Stroke 1993;24:527-31.
22. Goodwin JA, Gorelick PB, Helgason CM. Symptoms of amaurosis fugax in atherosclerotic carotid artery disease. Neurology 1987;37:829-32.
23. Donders RCJM. Transient monocular blindness. Diagnosis and prognosis of different subtypes [dissertation] The Netherlands, University Utrecht, 1999:57-74.
24. Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and longterm survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-40.
25. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Strote 2005;36:891-901.